Hepatitis B Virus Reactivation in Patients Receiving Bruton Tyrosine Kinase Inhibitors

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Norah A. Terrault, Anna S. Lok, Brian J. McMahon et al. · Hepatology · 2018 · 4.3K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections

Carla Casulo, Jocelyn Maragulia, Andrew D. Zelenetz · Clinical Lymphoma Myeloma & Leukemia · 2012 · 299 citations

Life Sciences, Immunology, Internal Medicine +10

Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib

Clare Sun, Xin Tian, Yuh Shan Lee et al. · Blood · 2015 · 221 citations · Full text

Life Sciences, Hematology, Immunology +14

Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update

Jessica Hwang, Jordan J. Feld, Sarah P. Hammond et al. · Journal of Clinical Oncology · 2020 · 198 citations · Full text

Medicine, Oncology, Cancer Screening +13

Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study

Wei Xu, Shenmiao Yang, Keshu Zhou et al. · Journal of Hematology & Oncology · 2020 · 129 citations · Full text

Medicine, Oncology, Pharmacology +15